Melanoma therapy requires three drugs administered in the correct sequence to activate the immune system against cancer, similar to a combination lock. The drugs include chemo/radiation to shed dead tumor cells and promote antigen presentation, anti-CTLA-4/antiPD-1 blockade to activate T cells while suppressing regulatory T cells, and interluekin-2 to activate and maintain cytotoxic T cells, with the goal of unleashing the immune system against cancer throughout the body.